Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl-2 Genes-Reference-Cited by-同舟云学术

Survival of Patients with Glioblastoma Multiforme is not Influenced by Altered Expression of P16, P53, EGFR, MDM2 or Bcl-2 Genes

Published:1998-10 Issue:4 Volume:8 Page:655-667
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:

Author:

Newcomb Elizabeth W.,Cohen Henry,Lee Suzanne R.,Bhalla Sandhya K.,Bloom Joanna,Hayes Roberta L.,Miller Douglas C.

Publisher

Wiley

Subject

Neurology (clinical),Pathology and Forensic Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1750-3639.1998.tb00191.x/fullpdf

Reference61 articles.

1. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme;Burger;Cancer,1987

2. Multivariate analysis of prognostic factors in 106 patients with malignant glioma;Salminen;Eur J Cancer,1996

3. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas;Iwadate;Int J Cancer,1996

4. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis;Gomez-Manzano;Cancer Res,1996

5. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation;Weller;J Clin Invest,1995

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDH1, ATRX, p53, and Ki67 Expression in Glioblastoma patients: Their Clinical and Prognostic Significance—A Prospective Study;Asian Journal of Neurosurgery;2024-03

2. Retrospective Evaluation of Cases Undergoing Stereotaxic Brain Biopsy;Asian Journal of Neurosurgery;2023-09

3. Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma;Heliyon;2023-07

4. Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy;Strahlentherapie und Onkologie;2022-05-25

5. Epidemiology of Glioblastoma Multiforme–Literature Review;Cancers;2022-05-13